| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
esterase activator | 0.716 | 0.308 |
|
disease | 0.100 | None | 0.990 | 96 | 0 | 1996 | 2019 | |||||||||
|
metallothionein 1J, pseudogene | 0.588 | 0.731 |
|
disease | 0.100 | None | 0.975 | 81 | 0 | 1995 | 2020 | |||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.100 | None | 0.929 | 14 | 5 | 2004 | 2019 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2006 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2006 | 2019 | |||||||||
|
mannose-binding lectin family member 3, pseudogene | 0.518 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2001 | 2018 | |||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2005 | 2019 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1991 | 2018 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2011 | 2019 | |||||||||
|
microRNA 29a | 0.459 | 0.808 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2013 | 2019 | |||||||||
|
H3 histone pseudogene 19 | 0.631 | 0.577 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1995 | 2017 | |||||||||
|
CACNA1G antisense RNA 1 | 0.736 | 0.346 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2006 | 2019 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2018 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2019 | |||||||||
|
cerebral palsy, ataxic 1 | 0.674 | 0.654 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2001 | 2017 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | |||||||||
|
Tuberculin skin test reactivity, absence of | 0.780 | 0.231 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2018 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2019 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2020 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
cone rod dystrophy 1 (autosomal dominant) | 0.722 | 0.423 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2019 | |||||||||
|
formyl peptide receptor 1 | 0.576 | 0.769 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2016 | 2018 | |||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2019 | |||||||||
|
microRNA 144 | 0.500 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2019 |